特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
963771

ワクチンの業界分析レポート:年齢層・疾患・技術・地域展望・アプリケーション可能性・価格動向・競合市場シェア & 予測 (2020-2026年)

Vaccines Market Size By Age Group, By Disease, By Technology, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 192 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
ワクチンの業界分析レポート:年齢層・疾患・技術・地域展望・アプリケーション可能性・価格動向・競合市場シェア & 予測 (2020-2026年)
出版日: 2020年10月08日
発行: Global Market Insights Inc.
ページ情報: 英文 192 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ワクチン市場は、高齢者人口の増加、小児人口の死亡リスクの高さ、COVID-19パンデミックとの継続的な戦い、髄膜炎菌性疾患に対する新しいワクチンの開発、およびそれぞれの医療インフラの統合に向けて政府が後援するさまざまなイニシアチブによって、今後数年間で大幅な拡大を示す可能性があります。

年齢層別では、成人セグメントは、予測期間を通じて16.7%以上のCAGRを示す見込みです。根底にある併存疾患と年齢による死亡リスクの高さ、高齢者人口の増加、COVID-19感染のリスクの高さなどの要因が、セグメント全体の成長をさらに促進すると予測されます。

当レポートでは、世界のワクチン市場について調査分析し、市場の概要、各セグメント・地域別の市場動向、市場規模の推移と予測、市場促進要因および阻害要因の分析、市場の将来展望、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査手法と範囲

  • 市場の定義
  • 基本推計&作業
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 予測計算
    • COVID-19が業界予測に与える影響の計算
  • データソース
    • 一次
    • 二次

第2章 エグゼクティブサマリー

  • ワクチン産業の全方位的概要
    • ビジネス動向
    • 年齢層動向
    • 疾患動向
    • 技術動向
    • 地域動向

第3章 ワクチン業界の考察

  • 業界セグメンテーション
  • 業界情勢
  • 業界への影響要因
    • 成長要因
    • 業界の潜在的リスク&課題
  • 成長の可能性の分析
    • 年齢層別
    • 疾患別
    • 技術別
  • COVID-19影響分析
    • COVID-19が主要市場に与える影響
    • COVID-19が業界のバリューチェーンに与える影響
    • COVID-19が業界の競合に与える影響
  • 技術情勢
  • 規制状況
    • 米国
    • 欧州
    • アジア太平洋
  • パイプライン分析
    • マラリア
    • HIV
    • ジカ熱
    • エボラ出血熱
    • COVID-19(新型コロナウイルス感染症)
  • 価格分析
  • 医療費償還シナリオ
    • 米国
    • 欧州
  • ポーターの分析
  • 企業の市場シェア分析
    • 戦略ダッシュボード
  • PESTEL分析

第4章 ワクチン市場:マテリアル別

  • 主要なセグメントの動向
  • 小児
    • 市場規模:地域別 (金額ベース)
  • 成人

第5章 ワクチン市場:疾患別

  • 主要なセグメントの動向
  • がん
    • 市場規模:地域別 (金額ベース)
  • 肺炎球菌感染症
  • DTP
  • デング熱
  • インフルエンザ
  • ヒトパピローマウイルス
  • 髄膜炎菌性疾患
  • ポリオ
  • ロタウイルス
  • その他

第6章 ワクチン市場:技術別

  • 主要なセグメントの動向
  • 結合型ワクチン
    • 市場規模:地域別 (金額ベース)
  • 生ワクチン
  • 不活化ワクチン
  • 組み換えワクチン
  • トキソイドワクチン
  • その他

第7章 ワクチン市場:地域別

  • 主要な地域の動向
  • 北米
    • 市場規模:国別 (金額ベース)
    • 市場規模:年齢層別 (金額ベース)
    • 市場規模:疾患別 (金額ベース)
    • 市場規模:技術別 (金額ベース)
    • 米国
    • カナダ
  • 欧州
    • 市場規模:国別 (金額ベース)
    • 市場規模:年齢層別 (金額ベース)
    • 市場規模:疾患別 (金額ベース)
    • 市場規模:技術別 (金額ベース)
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
  • アジア太平洋
    • 市場規模:国別 (金額ベース)
    • 市場規模:年齢層別 (金額ベース)
    • 市場規模:疾患別 (金額ベース)
    • 市場規模:技術別 (金額ベース)
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ (LATAM)
    • 市場規模:国別 (金額ベース)
    • 市場規模:年齢層別 (金額ベース)
    • 市場規模:疾患別 (金額ベース)
    • 市場規模:技術別 (金額ベース)
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ(MEA)
    • 市場規模:国別 (金額ベース)
    • 市場規模:年齢層別 (金額ベース)
    • 市場規模:疾患別 (金額ベース)
    • 市場規模:技術別 (金額ベース)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • エジプト

第8章 企業プロファイル

  • 競合ダッシュボード
  • Abbott Laboratories
  • Astellas Pharma, Inc.
  • AstraZeneca
  • Serum Institute of India Pvt. Ltd
  • CSL Limited
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co.
  • Novavax, Inc.
  • Pfizer
  • Sanofi Pasteur
図表

Data Tables

  • TABLE 1. Vaccines industry 360 degree synopsis, 2015 - 2019
  • TABLE 2. Global vaccines market, 2015 - 2019 (USD Million)
  • TABLE 3. Global vaccines market, 2020 - 2026 (USD Million)
  • TABLE 4. Global vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 5. Global vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 6. Global vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 7. Global vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 8. Global vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 9. Global vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 10. Global vaccines market, by region, 2015 - 2019 (USD Million)
  • TABLE 11. Global vaccines market, by region, 2020 - 2026 (USD Million)
  • TABLE 12. Industry impact forces
  • TABLE 13. Pediatric market size, by region, 2015 - 2019 (USD Million)
  • TABLE 14. Pediatric market size, by region, 2020 - 2026 (USD Million)
  • TABLE 15. Adult market size, by region, 2015 - 2019 (USD Million)
  • TABLE 16. Adult market size, by region, 2020 - 2026 (USD Million)
  • TABLE 17. Conjugate market size, by region, 2015 - 2019 (USD Million)
  • TABLE 18. Conjugate market size, by region, 2020 - 2026 (USD Million)
  • TABLE 19. Live acting market size, by region, 2015 - 2019 (USD Million)
  • TABLE 20. Live acting market size, by region, 2020 - 2026 (USD Million)
  • TABLE 21. Inactivated market size, by region, 2015 - 2019 (USD Million)
  • TABLE 22. Inactivated market size, by region, 2020 - 2026 (USD Million)
  • TABLE 23. Recombinant market size, by region, 2015 - 2019 (USD Million)
  • TABLE 24. Recombinant market size, by region, 2020 - 2026 (USD Million)
  • TABLE 25. Toxoid market size, by region, 2015 - 2019 (USD Million)
  • TABLE 26. Toxoid market size, by region, 2020 - 2026 (USD Million)
  • TABLE 27. Others market size, by region, 2015 - 2019 (USD Million)
  • TABLE 28. Others market size, by region, 2020 - 2026 (USD Million)
  • TABLE 29. Cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 30. Cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 31. Hepatitis market size, by region, 2015 - 2019 (USD Million)
  • TABLE 32. Hepatitis market size, by region, 2020 - 2026 (USD Million)
  • TABLE 33. Pneumococcal disease market size, by region, 2015 - 2019 (USD Million)
  • TABLE 34. Pneumococcal disease market size, by region, 2020 - 2026 (USD Million)
  • TABLE 35. DTP market size, by region, 2015 - 2019 (USD Million)
  • TABLE 36. DTP market size, by region, 2020 - 2026 (USD Million)
  • TABLE 37. Dengue inhibitors market size, by region, 2015 - 2019 (USD Million)
  • TABLE 38. Dengue market size, by region, 2020 - 2026 (USD Million)
  • TABLE 39. Influenza market size, by region, 2015 - 2019 (USD Million)
  • TABLE 40. Influenza market size, by region, 2020 - 2026 (USD Million)
  • TABLE 41. Human papillomavirus market size, by region, 2015 - 2019 (USD Million)
  • TABLE 42. Human papillomavirus market size, by region, 2020 - 2026 (USD Million)
  • TABLE 43. Meningococcal disease market size, by region, 2015 - 2019 (USD Million)
  • TABLE 44. Meningococcal disease market size, by region, 2020 - 2026 (USD Million)
  • TABLE 45. Polio market size, by region, 2015 - 2019 (USD Million)
  • TABLE 46. Polio market size, by region, 2020 - 2026 (USD Million)
  • TABLE 47. Rotavirus market size, by region, 2015 - 2019 (USD Million)
  • TABLE 48. Rotavirus market size, by region, 2020 - 2026 (USD Million)
  • TABLE 49. Others market size, by region, 2015 - 2019 (USD Million)
  • TABLE 50. Others market size, by region, 2020 - 2026 (USD Million)
  • TABLE 51. North America market, by country, 2015 - 2019 (USD Million)
  • TABLE 52. North America market, by country, 2020 - 2026 (USD Million)
  • TABLE 53. North America vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 54. North America vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 55. North America vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 56. North America vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 57. North America vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 58. North America vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 59. U.S. vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 60. U.S. vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 61. U.S. vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 62. U.S. vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 63. U.S. vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 64. U.S. vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 65. Canada vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 66. Canada vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 67. Canada vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 68. Canada vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 69. Canada vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 70. Canada vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 71. Europe market, by country, 2015 - 2019 (USD Million)
  • TABLE 72. Europe market, by country, 2020 - 2026 (USD Million)
  • TABLE 73. Europe vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 74. Europe vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 75. Europe vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 76. Europe vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 77. Europe vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 78. Europe vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 79. Germany vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 80. Germany vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 81. Germany vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 82. Germany vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 83. Germany vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 84. Germany vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 85. UK vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 86. UK vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 87. UK vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 88. UK vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 89. UK vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 90. UK vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 91. France vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 92. France vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 93. France vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 94. France vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 95. France vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 96. France vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 97. Italy vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 98. Italy vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 99. Italy vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 100. Italy vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 101. Italy vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 102. Italy vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 103. Spain vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 104. Spain vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 105. Spain vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 106. Spain vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 107. Spain vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 108. Spain vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 109. Russia vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 110. Russia vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 111. Russia vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 112. Russia vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 113. Russia vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 114. Russia vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 115. Asia Pacific market size, by country, 2015 - 2019 (USD Million)
  • TABLE 116. Asia Pacific market size, by country, 2020 - 2026 (USD Million)
  • TABLE 117. Asia Pacific vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 118. Asia Pacific vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 119. Asia Pacific vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 120. Asia Pacific vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 121. Asia Pacific vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 122. Asia Pacific vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 123. Japan vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 124. Japan vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 125. Japan vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 126. Japan vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 127. Japan vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 128. Japan vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 129. China vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 130. China vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 131. China vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 132. China vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 133. China vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 134. China vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 135. India vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 136. India vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 137. India vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 138. India vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 139. India vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 140. India vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 141. Australia vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 142. Australia vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 143. Australia vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 144. Australia vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 145. Australia vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 146. Australia vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 147. South Korea vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 148. South Korea vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 149. South Korea vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 150. South Korea vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 151. South Korea vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 152. South Korea vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 153. Latin America market size, by country, 2015 - 2019 (USD Million)
  • TABLE 154. Latin America market size, by country, 2020 - 2026 (USD Million)
  • TABLE 155. Latin America vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 156. Latin America vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 157. Latin America vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 158. Latin America vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 159. Latin America vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 160. Latin America vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 161. Brazil vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 162. Brazil vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 163. Brazil vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 164. Brazil vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 165. Brazil vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 166. Brazil vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 167. Mexico vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 168. Mexico vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 169. Mexico vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 170. Mexico vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 171. Mexico vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 172. Mexico vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 173. Argentina vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 174. Argentina vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 175. Argentina vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 176. Argentina vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 177. Argentina vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 178. Argentina vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 179. MEA market size, by country, 2015 - 2019 (USD Million)
  • TABLE 180. MEA market size, by country, 2020 - 2026 (USD Million)
  • TABLE 181. MEA vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 182. MEA vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 183. MEA vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 184. MEA vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 185. MEA vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 186. MEA vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 187. South Africa vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 188. South Africa vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 189. South Africa vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 190. South Africa vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 191. South Africa vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 192. South Africa vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 193. Saudi Arabia vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 194. Saudi Arabia vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 195. Saudi Arabia vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 196. Saudi Arabia vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 197. Saudi Arabia vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 198. Saudi Arabia vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 199. UAE vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 200. UAE vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 201. UAE vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 202. UAE vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 203. UAE vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 204. UAE vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 205. Qatar Arabia vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 206. Qatar Arabia vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 207. Qatar Arabia vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 208. Qatar Arabia vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 209. Qatar vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 210. Qatar vaccines market, by technology, 2020 - 2026 (USD Million)
  • TABLE 211. Egypt vaccines market, by age group, 2015 - 2019 (USD Million)
  • TABLE 212. Egypt vaccines market, by age group, 2020 - 2026 (USD Million)
  • TABLE 213. Egypt vaccines market, by disease, 2015 - 2019 (USD Million)
  • TABLE 214. Egypt vaccines market, by disease, 2020 - 2026 (USD Million)
  • TABLE 215. Egypt vaccines market, by technology, 2015 - 2019 (USD Million)
  • TABLE 216. Egypt vaccines market, by technology, 2020 - 2026 (USD Million)

Charts & Figures

  • FIG.1. Industry segmentation
  • FIG.2. Global vaccines market, 2015 - 2026 (USD Million)
  • FIG.3. Growth potential analysis, by age group
  • FIG.4. Growth potential analysis, by disease
  • FIG.5. Growth potential analysis, by technology
  • FIG.6. Porter's analysis
  • FIG.7. Company share analysis, 2019
  • FIG.8. Strategy dashboard, 2019
  • FIG.9. PESTEL analysis
目次
Product Code: 2186

Title:
Vaccines Market Size By Age Group (Pediatric, Adult), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), By Technology (Conjugate, Live, Inactivated, Recombinant, Toxoid), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026 .

The vaccines market is likely to register significant gains in coming years owing to the growing geriatric population, high risk of fatality among the pediatric population, the ongoing fight against the COVID-19 pandemic, development of new vaccines for meningococcal diseases, and various government-sponsored initiatives towards the consolidation of their respective healthcare infrastructure.

Vaccine is a type of medicine which essentially trains the body's immune system to effectively fight a disease which it has not encountered before. It is known as a biological substance specifically designed for protecting humans from infections mainly caused by viruses and bacteria. Generally, vaccines are given in the form of injection, but at times some of them are given nasally or even orally.

The vaccines market is bifurcated in terms of age group, disease, technology, and regional landscape.

Based on age group, the vaccines market is categorized into adult and pediatric. Among these, adult segment will witness more than 16.7% CAGR through the projected time period. Factors such as high risk of mortality due to underlying comorbidities and age, increasing geriatric population, and high risk of acquiring COVID-19 infection will further drive the overall segment growth.

As in children, vaccines are equally important for adults to protect them from various diseases that might have a serious or deadly consequences if left untreated. A common instance is the Flu shots that are recommended for elderly population during flu season. It is extremely essential for those who are suffering from chronic illnesses and those above the age of 65.

With respect to disease, the vaccines market is classified into rotavirus, polio, meningococcal disease, human papilloma virus, influenza, dengue, DTP, pneumococcal disease, hepatitis, cancer, and others. Among these, meningococcal disease segment will witness substantial growth over the coming years. Factors such as development of new vaccines for meningococcal diseases, high risk of fatality in pediatric population, and regulatory approvals will drive the segmental growth.

In terms of technology, the overall vaccines market is segmented into toxoid, recombinant, inactivated, live, conjugate, and others. Among these, inactivated technology segment is likely to grow at a CAGR of more than 22% over the forecast timeframe. Increasing focus of research institutes and pharmaceutical companies towards the development of an effective COVID-19 vaccine based on inactivated virus technology will contribute towards industry growth.

Inactivated vaccines are a form of vaccine, in which the virus is inactivated during the vaccine making process. Various inactivated vaccines are available as whole-cell inactivated vaccines and utilized to protect against diseases like rabies, hepatitis A, polio, and flu.

From a regional frame of reference, Asia-Pacific vaccines market is likely to witness tremendous gains owing to presence of large geriatric population, increasing government initiatives for the development of numerous vaccination programs, and rising awareness.

Table of Contents

Chapter 1. Methodology

  • 1.1. Market definitions
  • 1.2. Base estimates and working
    • 1.2.1. North America
    • 1.2.2. Europe
    • 1.2.3. Asia Pacific
    • 1.2.4. Latin America
    • 1.2.5. Middle east & Africa
  • 1.3. Forecast calculations
  • 1.4. Data validation
  • 1.5. Data sources
    • 1.5.1. Secondary
      • 1.5.1.1. Paid sources
      • 1.5.1.2. Unpaid sources
    • 1.5.2. Primary

Chapter 2. Executive Summary

  • 2.1. Vaccines industry 360 degree synopsis, 2015 - 2026
    • 2.1.1. Business trends
    • 2.1.2. Age group trends
    • 2.1.3. Disease trends
    • 2.1.4. Technology trends
    • 2.1.5. Regional trends

Chapter 3. Vaccines Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing government funding for vaccine development pertaining to COVID-19 situation
      • 3.3.1.2. Increasing disease prevalence in underdeveloped countries
      • 3.3.1.3. Growing incidence of cancer & HIV in Asia Pacific
      • 3.3.1.4. Increasing vaccines R&D in developed nations
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. High cost of vaccine storage and transportation
      • 3.3.2.2. Stringent regulations for the approval of vaccines in developed nations
      • 3.3.2.3. Drug-development hurdles
  • 3.4. Growth potential analysis
    • 3.4.1. By age group
    • 3.4.2. By disease
    • 3.4.3. By technology
  • 3.5. COVID-19 impact analysis
    • 3.5.1. Impact of COVID-19 on major markets, 2020-2022
      • 3.5.1.1. U.S.
      • 3.5.1.2. Canada
      • 3.5.1.3. Germany
      • 3.5.1.4. UK
      • 3.5.1.5. France
      • 3.5.1.6. Spain
      • 3.5.1.7. Italy
      • 3.5.1.8. Japan
      • 3.5.1.9. China
      • 3.5.1.10. India
    • 3.5.2. Impact of COVID-19 on industry value chain
      • 3.5.2.1. Research and development
      • 3.5.2.2. Manufacturing
      • 3.5.2.3. Marketing
      • 3.5.2.4. Supply
    • 3.5.3. Impact of COVID-19 on industry competition
      • 3.5.3.1. Strategy
      • 3.5.3.2. Product portfolio
      • 3.5.3.3. Business growth
  • 3.6. Technology landscape
  • 3.7. Regulatory landscape
    • 3.7.1. U.S.
    • 3.7.2. Europe
    • 3.7.3. Asia Pacific
  • 3.8. Pipeline analysis
    • 3.8.1. Malaria
    • 3.8.2. HIV
    • 3.8.3. Zika
    • 3.8.4. Ebola
    • 3.8.5. COVID-19
  • 3.9. Pricing analysis
  • 3.10. Reimbursement scenario
    • 3.10.1. U.S.
    • 3.10.2. Europe
  • 3.11. Porter's analysis
  • 3.12. Company market share analysis, 2019
    • 3.12.1. Strategy dashboard, 2019
  • 3.13. PESTEL analysis

Chapter 4. Vaccines Market, By Age Group

  • 4.1. Key segment trends
  • 4.2. Pediatric
    • 4.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.3. Adult
    • 4.3.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 5. Vaccines Market, By Disease

  • 5.1. Key segment trends
  • 5.2. Cancer
    • 5.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.3. Hepatitis
    • 5.3.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.4. Pneumococcal disease
    • 5.4.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.5. DTP
    • 5.5.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.6. Dengue
    • 5.6.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.7. Influenza
    • 5.7.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.8. Human papilloma virus
    • 5.8.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.9. Meningococcal disease
    • 5.9.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.10. Polio
    • 5.10.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.11. Rotavirus
    • 5.11.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.12. Others
    • 5.12.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 6. Vaccines Market, By Technology

  • 6.1. Key segment trends
  • 6.2. Conjugate
    • 6.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.3. Live
    • 6.3.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.4. Inactivated
    • 6.4.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.5. Recombinant
    • 6.5.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.6. Toxoid
    • 6.6.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.7. Others
    • 6.7.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 7. Vaccines Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size by country, 2015 - 2026 (USD Million)
    • 7.2.2. Market size by age group, 2015 - 2026 (USD Million)
    • 7.2.3. Market size by disease, 2015 - 2026 (USD Million)
    • 7.2.4. Market size by technology, 2015 - 2026 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.2.5.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.2.5.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.2.6.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.2.6.3. Market size by technology, 2015 - 2026 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size by country, 2015 - 2026 (USD Million)
    • 7.3.2. Market size by age group, 2015 - 2026 (USD Million)
    • 7.3.3. Market size by disease, 2015 - 2026 (USD Million)
    • 7.3.4. Market size by technology, 2015 - 2026 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.3.5.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.3.5.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.3.6.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.3.6.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.3.7.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.3.7.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.3.8.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.3.8.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.3.9.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.3.9.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.3.10. Russia
      • 7.3.10.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.3.10.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.3.10.3. Market size by technology, 2015 - 2026 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size by country, 2015 - 2026 (USD Million)
    • 7.4.2. Market size by age group, 2015 - 2026 (USD Million)
    • 7.4.3. Market size by disease, 2015 - 2026 (USD Million)
    • 7.4.4. Market size by technology, 2015 - 2026 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.4.5.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.4.5.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.4.6.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.4.6.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.4.7.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.4.7.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.4.8.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.4.8.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.4.9. South Korea
      • 7.4.9.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.4.9.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.4.9.3. Market size by technology, 2015 - 2026 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size by country, 2015 - 2026 (USD Million)
    • 7.5.2. Market size by age group, 2015 - 2026 (USD Million)
    • 7.5.3. Market size by disease, 2015 - 2026 (USD Million)
    • 7.5.4. Market size by technology, 2015 - 2026 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.5.5.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.5.5.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.5.6.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.5.6.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.5.7.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.5.7.3. Market size by technology, 2015 - 2026 (USD Million)
  • 7.6. Middle East & Africa (MEA)
    • 7.6.1. Market size by country, 2015 - 2026 (USD Million)
    • 7.6.2. Market size by age group, 2015 - 2026 (USD Million)
    • 7.6.3. Market size by disease, 2015 - 2026 (USD Million)
    • 7.6.4. Market size by technology, 2015 - 2026 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.6.5.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.6.5.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.6.6.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.6.6.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.6.7.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.6.7.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.6.8. Qatar
      • 7.6.8.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.6.8.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.6.8.3. Market size by technology, 2015 - 2026 (USD Million)
    • 7.6.9. Egypt
      • 7.6.9.1. Market size by age group, 2015 - 2026 (USD Million)
      • 7.6.9.2. Market size by disease, 2015 - 2026 (USD Million)
      • 7.6.9.3. Market size by technology, 2015 - 2026 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Competitive dashboard, 2019
  • 8.2. Abbott Laboratories
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Astellas Pharma, Inc.
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. AstraZeneca
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Serum Institute of India Pvt. Ltd
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. CSL Limited
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Emergent BioSolutions, Inc.
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. GlaxoSmithKline
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Johnson & Johnson
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Merck & Co.
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. Novavax, Inc.
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Pfizer
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Sanofi Pasteur
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.